Aavalium targets niche or difficult-to-source/manufacture pharmaceutical products for the US market. Our product pipeline ranges from generic, 505(b)(2) to NCEs, covering a wide range of therapeutic areas and dosage forms. We aim to out-license our products to business partners for further development and/or commercialization. We continually look for partnership opportunities to co-develop new products.
Aavalium, Inc.
Copyright © 2024 Aavalium, Inc. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.